ArticleACS synthetic biology2025
Characterizing and Engineering a Succinate-Responsive Biosensor System in
Article in ACS synthetic biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Engineering theACS synthetic biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Metabolic engineering enables the sustainable production of valuable compounds, but challenges such as metabolic imbalances and limited regulatory tools hinder optimal yields and efficiencies. Transcription factor (TF)-based biosensors have emerged as robust solutions, allowing dynamic sensing and regulation of intracellular metabolites. However, their limited diversity often restricts their broader applications in metabolic engineering. To overcome this limitation, it is essential to develop biosensors that are responsive to central metabolic intermediates, enabling more versatile pathway control. In this study, we characterized a succinate-responsive biosensor system regulated by the IclR family TF, PcaR, and elucidated the dual-function mechanism observed in this PcaR biosensor system. Initially, we fine-tuned the expression of PcaR, fully recovering the corresponding promoter strength. Then, we discovered a dual-function mechanism of PcaR through homologue pairing, further elucidated by employing site-directed mutagenesis and promoter engineering. Meanwhile, we established a succinate-responsive biosensor library guided by PcaR-succinate complex analysis with varied dynamic ranges, identifying the superior P1-AII variant with nearly a 33-fold improvement in dynamic range. Finally, we constructed a bifunctional regulatory circuit controlled by succinate and a single regulator, demonstrating its potential for dynamic metabolic regulation. Given the primary role of succinate in central metabolism, the engineered PcaR biosensor system provides a promising tool for real-time metabolic monitoring and optimization of microbial production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.